Related references
Note: Only part of the references are listed.Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis
Ilijas Jelcic et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2019)
Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders
Mickael Bonnan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
Sudarshini Ramanathan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Maria Sepulveda et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Maria Sepulveda et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Frederike C. Oertel et al.
EPMA JOURNAL (2018)
Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review
Kevin Yuqi Wang et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes
Sophie Duignan et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
Investigational drugs in development to prevent neuromyelitis optica relapses
Friedemann Paul et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2018)
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study
Philippe Cabre et al.
JOURNAL OF NEUROLOGY (2018)
Worldwide prevalence of neuromyelitis optica spectrum disorders
Masahiro Mori et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study
Frederike C. Oertel et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and lower dosages of rituximab among patients with neuromyelitis optica spectrum disorder
Yang Yang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
The current role of MRI in differentiating multiple sclerosis from its imaging mimics
Ruth Geraldes et al.
NATURE REVIEWS NEUROLOGY (2018)
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults The MOGADOR study
Alvaro Cobo-Calvo et al.
NEUROLOGY (2018)
Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
J. Ciron et al.
REVUE NEUROLOGIQUE (2018)
Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization
Carsten Finke et al.
JAMA NEUROLOGY (2018)
Disease Course and Treatment Responses in Children With RelapsingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Yael Hacohen et al.
JAMA NEUROLOGY (2018)
Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease
Shahd H. M. Hamid et al.
JAMA NEUROLOGY (2018)
Treatment for paraneoplastic neuromyelitis optica spectrum disorder (NMOsd): Probable effects of tocilizumab for both cancer and NMOsd
Masami Tanaka et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation
Philippe Beauchemin et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patients
Edgar Carnero Contentti et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Frequent retinal ganglion cell damage after acute optic neuritis
Alexander U. Brandt et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
Giordani Rodrigues dos Passos et al.
FRONTIERS IN NEUROLOGY (2018)
Optical coherence tomography in acute optic neuritis: A population-based study
Kerstin Soelberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
Ram Narayan et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS
Yuyi You et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Multicenter reliability of semiautomatic retinal layer segmentation using OCT
Timm Oberwahrenbrock et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Temporal visual resolution and disease severity in MS
Noah Ayadi et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
Felix Luessi et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
Andrea Marcinno et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Apheresis therapies for NMOSD attacks A retrospective study of 207 therapeutic interventions
Ingo Kleiter et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Rituximab before and during pregnancy A systematic review, and a case series in MS and NMOSD
Gitanjali Das et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Monitoring B-cell repopulation after depletion therapy in neurologic patients
Erik Ellwardt et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder
H. Chen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration
Joachim Havla et al.
JOURNAL OF NEUROLOGY (2017)
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
Maciej Jurynczyk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates
Shahd H. M. Hamid et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
Alexis Montcuquet et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Nadja Borisow et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates
Shahd H. M. Hamid et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
Alexis Montcuquet et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Nadja Borisow et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Neuromyelitis optica
Florence Pache et al.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE (2017)
Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica
Tetsuya Akaishi et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
The clinical characteristics of AQP4 antibody positive NMO/SD in a large cohort of Chinese Han patients
Jingzi ZhangBao et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
Zahra Nikoo et al.
JOURNAL OF NEUROLOGY (2017)
What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients
Shahd H. M. Hamid et al.
JOURNAL OF NEUROLOGY (2017)
MOG antibody-related disorders: common features and uncommon presentations
Alvaro Cobo-Calvo et al.
JOURNAL OF NEUROLOGY (2017)
Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies
Juichi Fujimori et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Jan-Patrick Stellmann et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases
Jae-Won Hyun et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Monitoring CD27+memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study
M. Cohen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up
M. E. Evangelopoulos et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Neuromyelitis Spectrum Disorders
Brian G. Weinshenker et al.
MAYO CLINIC PROCEEDINGS (2017)
A population-based prospective study of optic neuritis
K. Soelberg et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others?
Jun-ichi Kira
MULTIPLE SCLEROSIS JOURNAL (2017)
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder
Bassem I. Yamout et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Fatigue as a symptom or comorbidity of neurological diseases
Iris-Katharina Penner et al.
Nature Reviews Neurology (2017)
Optical coherence tomography in neuromyelitis optica spectrum disorders
F. C. Oertel et al.
NERVENARZT (2017)
Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy
Su-Hyun Kim et al.
JAMA NEUROLOGY (2017)
A population-based prospective study of optic neuritis
K. Soelberg et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others?
Jun-ichi Kira
MULTIPLE SCLEROSIS JOURNAL (2017)
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder
Bassem I. Yamout et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody
Moli Fan et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature
Saharat Aungsumart et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders
Felix Schmidt et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study
Remi A. Kessler et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study
Hadas Stiebel-Kalish et al.
PLOS ONE (2017)
Frequencies of neuronal autoantibodies in healthy controls Estimation of disease specificity
Katharina Lang et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Muscle damage in patients with neuromyelitis optica spectrum disorder
Hong-xi Chen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro
Yukio Takeshita et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study
Riley Bove et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Jurynczyk et al.
BRAIN (2017)
Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
Nasrin Asgari et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS
Anna Gahlen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Optical coherence tomography and visual evoked potentials in pediatric MS
Amy T. Waldman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Effectiveness of low dose of rituximab compared with azathioprine in Chinese patients with neuromyelitis optica: an over 2-year follow-up study
Meini Zhang et al.
ACTA NEUROLOGICA BELGICA (2017)
ADEM-LIKE PRESENTATION, ANTI-MOG ANTIBODIES, AND MS PATHOLOGY: TWO CASE REPORTS
Peter Koervelyessy et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Microstructural visual system changes in AQP4-antibody-seropositive NMOSD
Frederike C. Oertel et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
Ryo Ogawa et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis
Maciej Jurynczyk et al.
BRAIN (2017)
Aquaporin-4 antibody titration in NMO patients treated with rituximab A retrospective study
Paola Valentino et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients
Eoin P. Flanagan et al.
ANNALS OF NEUROLOGY (2017)
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
Ingo Kleiter et al.
ANNALS OF NEUROLOGY (2016)
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands
E. D. van Pelt et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants
Giulia Berzero et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)
P. S. Rommer et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series
Laura Azzopardi et al.
JOURNAL OF NEUROLOGY (2016)
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study
Tetsuya Akaishi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange
Hesham Abboud et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
M. Radaelli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations
Bruce A. C. Cree et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
Sudarshini Ramanathan et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging
Yeliz Pekcevik et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
Ingo Kleiter et al.
NEUROTHERAPEUTICS (2016)
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants
Giulia Berzero et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange
Hesham Abboud et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
M. Radaelli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations
Bruce A. C. Cree et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging
Yeliz Pekcevik et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
Sudarshini Ramanathan et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Discriminating Long Myelitis of Neuromyelitis Optica from Sarcoidosis
Eoin P. Flanagan et al.
ANNALS OF NEUROLOGY (2016)
The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China
Hongxi Chen et al.
CLINICAL NEUROPHARMACOLOGY (2016)
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study
F. Pache et al.
EUROPEAN RADIOLOGY (2016)
Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica
Tetsuya Akaishi et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
Florence Pache et al.
JOURNAL OF NEUROINFLAMMATION (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
Ilya Ayzenberg et al.
JOURNAL OF NEUROLOGY (2016)
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder
In Hye Jeong et al.
JOURNAL OF NEUROLOGY (2016)
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Patrick Waters et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case
Sven Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder
Jae-Won Hyun et al.
NEUROLOGY (2016)
Acute disseminated encephalomyelitis Updates on an inflammatory CNS syndrome
Daniela Pohl et al.
NEUROLOGY (2016)
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders A Systematic Review and Meta-analysis
Valentina Damato et al.
JAMA NEUROLOGY (2016)
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy A Novel Meningoencephalomyelitis
Boyan Fang et al.
JAMA NEUROLOGY (2016)
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case
Sven Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Neuromyelitis optica-relapses: Race and rate, immunosuppression and impairment
George Tackley et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder
Fumihito Yoshii et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders
Elena H. Martinez-Lapiscina et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Immunoadsorption in patients with neuromyelitis optica spectrum disorder
Simon Faissner et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
Ding Chen et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Neuromyelitis optica spectrum disorders Comparison according to the phenotype and serostatus
Maria Sepulveda et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD
Carsten Finke et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
Margherita Nosadini et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
Imke Metz et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Clinical utility of testing AQP4-IgG in CSF Guidance for physicians
Masoud Majed et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Melania Spadaro et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Restoring immune tolerance in neuromyelitis optica Part I
Larry Steinman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Restoring immune tolerance in neuromyelitis optica Part II
Amit Bar-Or et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Optic neuropathy associated with systemic sarcoidosis
Desmond P. Kidd et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
Velina S. Chavarro et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica
Wei Qiu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Intravenous immunoglobulin may reduce relapse frequency in neuromyelitis optica
Shanthi Viswanathan et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75
Markus Krumbholz et al.
JOURNAL OF NEUROLOGY (2015)
Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
Helene Zephir et al.
JOURNAL OF NEUROLOGY (2015)
Analysis of the treatment of neuromyelitis optica
Jose Torres et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
J. L. Bennett et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Demographic and clinical features of neuromyelitis optica: A review
L. Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Pushing the boundaries of neuromyelitis optica
Ilya Kister et al.
NEUROLOGY (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
MRI characteristics of neuromyelitis optica spectrum disorder An international update
Ho Jin Kim et al.
NEUROLOGY (2015)
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder
Stephane Kremer et al.
JAMA NEUROLOGY (2015)
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein et al.
JAMA NEUROLOGY (2015)
Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica Influence of FCGR3A Polymorphisms on the Therapeutic Response to Rituximab
Su-Hyun Kim et al.
JAMA NEUROLOGY (2015)
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders
Eoin P. Flanagan et al.
JAMA NEUROLOGY (2015)
Demographic and clinical features of neuromyelitis optica: A review
L. Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
J. L. Bennett et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease
Romana Hoeftberger et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Aquaporin-4 autoimmunity
Anastasia Zekeridou et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Update on biomarkers in neuromyelitis optica
Esther Melamed et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Patrick Waters et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Sleep abnormality in neuromyelitis optica spectrum disorder
Yijun Song et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
B lymphocytes in neuromyelitis optica
Jeffrey L. Bennett et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
Yael Hacohen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
Melania Spadaro et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
DoesMOGIg-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Scott S. Zamvil et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Specific Pattern of Gadolinium Enhancement in Spondylotic Myelopathy
Eoin P. Flanagan et al.
ANNALS OF NEUROLOGY (2014)
A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica
Anand Iyer et al.
AUTOIMMUNITY (2014)
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Ramnath Santosh Ramanathan et al.
BMC NEUROLOGY (2014)
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
S. Jarius et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Corinna Trebst et al.
JOURNAL OF NEUROLOGY (2014)
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients
L. Kremer et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients
Liene Elsone et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Bright spotty lesions on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis
Tadahiro Yonezu et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
Liene Elsone et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
The investigation of acute optic neuritis: a review and proposed protocol
Axel Petzold et al.
NATURE REVIEWS NEUROLOGY (2014)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Douglas Kazutoshi Sato et al.
NEUROLOGY (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
Seroprevalence of Aquaporin-4-IgG in a Northern California Population Representative Cohort of Multiple Sclerosis
Sean J. Pittock et al.
JAMA NEUROLOGY (2014)
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Joanna Kitley et al.
JAMA NEUROLOGY (2014)
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO
Jeffrey M. Gelfand et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
Russell C. Dale et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study
Nasrin Asgari et al.
BMC NEUROLOGY (2013)
Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients
A. Kiyat-Atamer et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Sarcoidosis associated with neuromyelitis optica
Raja Sawaya et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
The history of neuromyelitis optica
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study
Philippe Cabre et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Joanna Kitley et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Hope for a rare disease: eculizumab in neuromyelitis optica
Friedemann Paul
LANCET NEUROLOGY (2013)
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Sean J. Pittock et al.
LANCET NEUROLOGY (2013)
Longitudinal follow-up of vision in a neuromyelitis optica cohort
M. Bouyon et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient
Nasrin Asgari et al.
NEUROLOGY (2013)
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Yujuan Jiao et al.
NEUROLOGY (2013)
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis
Elisa Schneider et al.
PLOS ONE (2013)
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People
Fahmy Aboul-Enein et al.
PLOS ONE (2013)
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica
Jeffrey M. Gelfand et al.
JAMA NEUROLOGY (2013)
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
Su-Hyun Kim et al.
JAMA NEUROLOGY (2013)
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2012)
Lack of Response to Pulse Cyclophosphamide in Neuromyelitis Optica: Evaluation of 7 Patients
Denis B. Bichuetti et al.
ARCHIVES OF NEUROLOGY (2012)
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Ingo Kleiter et al.
ARCHIVES OF NEUROLOGY (2012)
Treatment of Optic Neuritis by Plasma Exchange (Add-On) in Neuromyelitis Optica
Harold Merle et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
S. Jarius et al.
JOURNAL OF NEUROLOGY (2012)
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature
S. Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
Ju-Hong Min et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
Anke Stroet et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
Su-Hyun Kim et al.
ARCHIVES OF NEUROLOGY (2011)
Prominent brainstem symptoms/signs in patients with neuromyelitis optica in a Taiwanese population
Kai-Chen Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children
P. H. Lalive et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders
Sven Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Azathioprine Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
C. Costanzi et al.
NEUROLOGY (2011)
Elevated Intrathecal Myelin Oligodendrocyte Glycoprotein Antibodies in Multiple Sclerosis
Eric C. Klawiter et al.
ARCHIVES OF NEUROLOGY (2010)
Interferon Beta Treatment in Neuromyelitis Optica Increase in Relapses and Aquaporin 4 Antibody Titers
Jacqueline Palace et al.
ARCHIVES OF NEUROLOGY (2010)
Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature
Paira Sergio et al.
CLINICAL RHEUMATOLOGY (2010)
Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica
Masahiko Nakamura et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis
Sven Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Neuromyelitis optica in France A multicenter study of 125 patients
N. Collongues et al.
NEUROLOGY (2010)
Antibodies to Native Myelin Oligodendrocyte Glycoprotein in Children with Inflammatory Demyelinating Central Nervous System Disease
Fabienne Brilot et al.
ANNALS OF NEUROLOGY (2009)
Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2009)
Narcolepsy as an initial manifestation of neuromyelitis optica with antiaquaporin-4 antibody
Toru Baba et al.
JOURNAL OF NEUROLOGY (2009)
Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis
Akiyuki Uzawa et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Neuromyelitis optica: Effect of gender
Dean M. Wingerchuk
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
SEVERE CARDIAC FAILURE IN A PATIENT WITH MULTIPLE SCLEROSIS FOLLOWING LOW-DOSE MITOXANTRONE TREATMENT
J. Doerr et al.
NEUROLOGY (2009)
Neuromyelitis Optica and non-organ-specific Autoimmunity
Sean J. Pittock et al.
ARCHIVES OF NEUROLOGY (2008)
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
S. Jarius et al.
BRAIN (2008)
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica
Sven Jarius et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis
S. Watanabe et al.
MULTIPLE SCLEROSIS (2007)
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
T. Misu et al.
BRAIN (2007)
Brain magnetic resonance imaging findings in relapsing neuromyelitis optica
Jose A. Cabrera-Gomez et al.
MULTIPLE SCLEROSIS (2007)
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
C. Papeix et al.
MULTIPLE SCLEROSIS (2007)
Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
F. Paul et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Brain abnormalities in neuromyelitis optica
SJ Pittock et al.
ARCHIVES OF NEUROLOGY (2006)
An open label study of the effects of rituximab in neuromyelitis optica
BAC Cree et al.
NEUROLOGY (2005)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function
P Vourc'h et al.
BRAIN RESEARCH REVIEWS (2004)
Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100β and myelin basic protein in patients with Devic's neuromyelitis optica
CG Haase et al.
NEUROSCIENCE LETTERS (2001)
Share Paper
